Verano Holdings (VRNO) Depreciation and Depletion (2021 - 2026)

Verano Holdings' (VRNO) quarterly Depreciation and Depletion came in at $4.8 million in Q1 2026, down 5.33% year-on-year from $5.1 million in Q1 2025, and down 89.04% on a QoQ basis from $44.2 million in Q4 2025.

Verano Holdings (VRNO) Depreciation and Depletion (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Depreciation and Depletion data on file, last reported at $4.8 million in Q1 2026.

  • On a quarterly basis, Depreciation and Depletion fell 5.33% year-over-year to $4.8 million in Q1 2026; TTM through Mar 2026 was $63.8 million, a 5.39% increase from a year earlier, with the FY2025 full-year figure at $59.2 million, up 8.99% from the prior year.
  • Depreciation and Depletion for Q1 2026 stood at $4.8 million, down from $44.2 million in the prior quarter.
  • Over the last five years, Depreciation and Depletion for VRNO reached as high as $44.2 million in Q4 2025 and fell as low as -$5.9 million in Q3 2022.
  • Historically, Depreciation and Depletion has averaged $11.7 million across 5 years, with a median of $5.1 million in 2025.
  • Across the five-year window, Depreciation and Depletion slumped 403.62% in 2022 and soared 211.01% in 2023, its largest moves.
  • Year by year, Depreciation and Depletion stood at $12.3 million in 2022, then surged by 211.01% to $38.2 million in 2023, then increased by 9.43% to $41.8 million in 2024, then rose by 5.96% to $44.2 million in 2025, then tumbled by 89.04% to $4.8 million in 2026.
  • Per Business Quant data, the three most recent Depreciation and Depletion figures were $4.8 million in Q1 2026, $44.2 million in Q4 2025, and $4.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 36.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 21.60 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 7.20 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 28.00 Mn
10 Verano Holdings 2.02 Bn 1.94 Bn 98.98 Mn 4.85 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 4.85 Mn
Mar 31, 2026 4.85 Mn
Dec 31, 2025 44.24 Mn
Dec 31, 2025 44.24 Mn
Sep 30, 2025 4.90 Mn
Sep 30, 2025 4.90 Mn
Jun 30, 2025 9.78 Mn
Jun 30, 2025 9.78 Mn
Mar 31, 2025 5.12 Mn
Mar 31, 2025 5.12 Mn
Dec 31, 2024 41.75 Mn
Dec 31, 2024 41.75 Mn
Sep 30, 2024 9.51 Mn
Sep 30, 2024 9.51 Mn
Jun 30, 2024 4.12 Mn
Jun 30, 2024 4.12 Mn
Mar 31, 2024 4.04 Mn
Mar 31, 2024 4.04 Mn
Dec 31, 2023 38.16 Mn
Dec 31, 2023 38.16 Mn